Smartbax Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
9
Smartbax General Information
Description
Developer of novel antibacterial compounds designed to treat bacterial infections by targeting unexploited bacterial mechanisms. The company offers antibacterial products with multiple mechanisms of action against drug-resistant pathogens, enabling patients and healthcare providers to address infections caused by resistant bacteria.
Contact Information
Website
www.smartbax.deCorporate Office
- Ingolstädter Landstraße 1
- 85764 Upper Schleissheim
- Germany
Corporate Office
- Ingolstädter Landstraße 1
- 85764 Upper Schleissheim
- Germany
Smartbax Timeline
Smartbax Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Smartbax Signals
Smartbax Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Smartbax FAQs
-
When was Smartbax founded?
Smartbax was founded in 2021.
-
Where is Smartbax headquartered?
Smartbax is headquartered in Upper Schleissheim, Germany.
-
What is the size of Smartbax?
Smartbax has 7 total employees.
-
What industry is Smartbax in?
Smartbax’s primary industry is Drug Discovery.
-
Is Smartbax a private or public company?
Smartbax is a Private company.
-
What is Smartbax’s current revenue?
The current revenue for Smartbax is .
-
How much funding has Smartbax raised over time?
Smartbax has raised $15M.
-
Who are Smartbax’s investors?
Anobis Asset, Bayern Kapital, UnternehmerTUM, High-Tech Gründerfonds, and INCATE are 5 of 10 investors who have invested in Smartbax.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process